Mitchell Allen

Mitchell Allen is a Senior Medical Science Liaison specializing in rare disease and oncology at SpringWorks Therapeutics, with extensive experience in establishing scientific relationships with key opinion leaders and facilitating the exchange of scientific information. Previously, Mitchell served as a Senior Medical Science Liaison at Sobi - North America, engaging in scientific education regarding therapies in rare disease and hematology/oncology. Earlier roles included Patient Diagnosis Liaison at Ultragenyx Pharmaceutical Inc. and Researcher at Stealth BioTherapeutics, where Mitchell achieved recognition for award-winning presentations. Educational background includes a PhD in Physiology and Metabolism from Virginia Tech, an MS in Exercise Physiology from South Dakota State University, and a BS in Kinesiology and Exercise Science from James Madison University.